Pathogenesis of E‐Cigarette Vaping Product Use‐Associated Lung Injury (EVALI)
Comprehensive Physiology · 2023-03-30 · 4617-4630
DOI: 10.1002/cphy.c220022 ↗At a glance
Journal article in Comprehensive Physiology, published on 2023-03-30. Written by Irina Petrache and 5 co-authors. Institution: National Jewish Health, Medicine, Denver, Colorado, USA. Major MEDLINE topics: Lung Injury, Electronic Nicotine Delivery Systems, COVID-19, Vaping. Cited 4 times so far (Crossref); 141 references. The full text is freely available in PubMed Central. Funded by: NHLBI NIH HHS.
Abstract (original language)
Intet abstract tilgængeligt.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- National Jewish Health, Medicine, Denver, Colorado, USA.
- University of Colorado School of Medicine, Aurora, Colorado, USA.
Funding
- NHLBI NIH HHS
Cite
APA
Petrache, I., Gupta, A., Hume, P. S., Rivera, T., Schweitzer, K. S., & Chu, H. W. (2023). Pathogenesis of E‐Cigarette Vaping Product Use‐Associated Lung Injury (EVALI). Comprehensive Physiology. https://doi.org/10.1002/cphy.c220022
Vancouver
Petrache I, Gupta A, Hume PS, Rivera T, Schweitzer KS, Chu HW. Pathogenesis of E‐Cigarette Vaping Product Use‐Associated Lung Injury (EVALI). Comprehensive Physiology. 2023. doi:10.1002/cphy.c220022
BibTeX
@article{Petrache2023,
author = {Petrache, Irina and Gupta, Arnav and Hume, Patrick S and Rivera, Tanner and Schweitzer, Kelly S and Chu, Hong Wei},
title = {Pathogenesis of E‐Cigarette Vaping Product Use‐Associated Lung Injury (EVALI)},
journal = {Comprehensive Physiology},
year = {2023},
doi = {10.1002/cphy.c220022}
}
EUVIMED